Zhaoke Ophthalmology Limited (HKG:6622)

Revenue by Product

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023
Licensing	36.35M
Ophthalmic Drugs	33.01M
Ophthalmic Drugs Growth	530.72%
Other Drug	2.33M
Opthalmic Products	2.17M
Opthalmic Products Growth	-76.64%
Exclusive Distribution Rights	1.31M
Exclusive Distribution Rights Growth	-78.90%

Revenue by Geography

Financials in millions HKD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023
China	72.99M
China Growth	433.49%
South Korea	1.29M
South Korea Growth	-79.08%
Hong Kong	870.63K
Hong Kong Growth	2.46%
Other	10.84K